MedTrace Logo

Thalassaemia Severity

NCT06720480 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2024-12-06

No results posted yet for this study

Summary

This study aims to develop a nuanced understanding of thalassemia severity in Upper Egypt by integrating various clinical parameters beyond transfusion frequency. By doing so, it seeks to enhance patient management and ultimately improve quality of life for those affected by this condition.

Conditions

  • Thalassaemia

Interventions

DIAGNOSTIC_TEST

Homglobin Electrophoresis

To diagnose thalassaemia \&best method to control disease progress

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Shereen Mansour Galal, Associate professor · Assiut University

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-31
Primary Completion
2025-12-01
Completion
2025-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06720480 on ClinicalTrials.gov